CoChat

HERV‐K(HML‐2) GAG/ENV antibodies as indicator for therapy effect in patients with germ cell tumors

Kleiman, Anna, Senyuta, Natalia, Tryakin, Alexey, Sauter, Marlies, Karseladze, Apollon, Tjulandin, Sergei, Gurtsevitch, Vladimir, Mueller‐Lantzsch, Nikolaus · 2004 · International Journal of Cancer
Cited by 70

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Germ cell tumors (GCT) are strictly associated with the expression of HERV‐K(HML‐2) proviruses, and the majority of GCT patients produce antibodies to structural proteins of these proviruses. The objective of our study was to determine the significance of the serological response to HERV‐K(HML‐2) Gag and Env proteins for diagnosis, management of GCT patients and estimation of the therapy success. The data document a strong association of HERV‐K(HML‐2) antibodies and the clinical manifestation of the disease and therapy success. HERV‐K(HML‐2) antibodies seem to have an important diagnostic value as well as indicator of chemotherapy success. © 2004 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijc.11649

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 70

Metadata

Authors
Kleiman, A., Senyuta, N., Tryakin, A., Sauter, M., Karseladze, A., Tjulandin, S., Gurtsevitch, V., & Mueller‐Lantzsch, N.
Venue
International Journal of Cancer
Publisher
Wiley
Published
2004-02-27
Volume
110
Issue
3
Pages
459-461
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W2073465064
Cited by
70
References
1
FWCI
3.33
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.